BMPs: from bone to body morphogenetic proteins
- PMID: 20124549
- DOI: 10.1126/scisignal.3107mr1
BMPs: from bone to body morphogenetic proteins
Abstract
The family of bone morphogenetic proteins (BMPs) comprises approximately 30 secreted cytokines that signal through transmembrane serine/threonine kinase receptors. The BMP signaling pathways are fine-tuned on multiple levels: Extracellular antagonists modify ligand activity; several co-receptors enhance or inhibit downstream signaling events through multiple mechanisms; and intracellular molecules further regulate the signaling outcome and mediate crosstalk with other pathways. BMPs affect structures and processes throughout the entire body, ranging from embryonic patterning and development through stem cells and their niches, to tissue homeostasis and regeneration. This comprehensive involvement in various tissues had not been expected by Marshall Urist, who initially discovered the ability of an unknown factor in bone to induce bone growth in muscle and subsequently suggested the name "bone morphogenetic protein." Today, recombinant BMPs are used in clinical practice for the treatment of bone and kidney disorders, and new genetically modified BMPs are emerging as promising tools in regenerative medicine and tissue engineering. Clearly, the functions of BMPs within the body are more versatile than initially suspected. To discuss modern trends in BMP signaling, leaders in the field met for the First International BMP Workshop in Berlin in September 2009. Here, we summarize new insights on the roles of BMPs in various tissues and highlight recent findings in cell, structural, and developmental biology as well as the therapeutic potential of BMPs. Finally, we conclude that BMPs today deserve to be called body morphogenetic proteins.
Similar articles
-
Bone morphogenetic proteins.Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890. Growth Factors. 2004. PMID: 15621726 Review.
-
Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.Vitam Horm. 2015;99:293-322. doi: 10.1016/bs.vh.2015.06.002. Epub 2015 Jul 15. Vitam Horm. 2015. PMID: 26279381 Review.
-
Bone morphogenetic proteins and their antagonists.Rev Endocr Metab Disord. 2006 Jun;7(1-2):51-65. doi: 10.1007/s11154-006-9000-6. Rev Endocr Metab Disord. 2006. PMID: 17029022 Review.
-
Bmp modulators in kidney disease.Discov Med. 2012 Jan;13(68):57-63. Discov Med. 2012. PMID: 22284784 Review.
-
Bone morphogenetic proteins, their antagonists, and the skeleton.Endocr Rev. 2003 Apr;24(2):218-35. doi: 10.1210/er.2002-0023. Endocr Rev. 2003. PMID: 12700180 Review.
Cited by
-
Specific amino acids from the broad C-terminal region of BMP-2 are crucial for osteogenesis.Bone Rep. 2021 May 8;14:101092. doi: 10.1016/j.bonr.2021.101092. eCollection 2021 Jun. Bone Rep. 2021. PMID: 34026953 Free PMC article.
-
Copresentation of BMP-6 and RGD Ligands Enhances Cell Adhesion and BMP-Mediated Signaling.Cells. 2019 Dec 15;8(12):1646. doi: 10.3390/cells8121646. Cells. 2019. PMID: 31847477 Free PMC article.
-
Congenital hallux valgus occurs in Fibrodysplasia Ossificans Progressiva and BMPR1B-associated dysplasia: an important distinction.BMC Med Genomics. 2024 Jun 15;17(1):160. doi: 10.1186/s12920-024-01931-6. BMC Med Genomics. 2024. PMID: 38879467 Free PMC article.
-
Expression of Bone Morphogenetic Protein-2 and Histological Differentiation of Oral Squamous Cell Carcinomas.Asian Pac J Cancer Prev. 2016 Dec 1;17(12):5243-5245. doi: 10.22034/APJCP.2016.17.12.5243. Asian Pac J Cancer Prev. 2016. PMID: 28125868 Free PMC article.
-
Small-Molecule Probes as Pharmacological Tools for the Bone Morphogenetic Protein Signaling Pathway.ACS Pharmacol Transl Sci. 2023 Oct 27;6(11):1574-1599. doi: 10.1021/acsptsci.3c00170. eCollection 2023 Nov 10. ACS Pharmacol Transl Sci. 2023. PMID: 37974621 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous